Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
05/13/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NMIHNMI Holdings Inc
05/13/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NMIHNMI Holdings Inc
05/13/20248:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SSNCSS and C Technologies Holdings Inc
05/13/20248:30PMBusiness WireCue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)NASDAQ:HLTHCue Health Inc
05/13/20248:30PMPR Newswire (Canada)Filo Receives $2M and Retains a 1% NSR on NGEx's Lunahuasi and Lundin Mining's Cumbre Verde; Publishes 2023 Sustainability SummaryTSX:FILFilo Corp
05/13/20248:30PMPR Newswire (US)ZENVIA Reports Q4 2023 and FY 2023 Results
05/13/20248:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NMIHNMI Holdings Inc
05/13/20248:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LVWRLivewire Group Inc
05/13/20248:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:22PMBusiness WirePresident Macron Hosts Skydweller Aero CEO at Choose France 2024
05/13/20248:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:21PMBusiness WireBerry Global Announces Pricing of Offering of First Priority Senior Secured NotesNYSE:BERYBerry Global Group Inc
05/13/20248:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSGSCSG Systems International Inc
05/13/20248:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PGProcter and Gamble Co
05/13/20248:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:18PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:TEFOFTelefonica SA (PK)
05/13/20248:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:OIIOceaneering International Inc
05/13/20248:13PMGlobeNewswire Inc.Constellation Software Inc. Announces Results of Voting for Directors at Annual Shareholders' MeetingTSX:CSUConstellation Software Inc
05/13/20248:12PMPR Newswire (US)Global Times: Xi's Footsteps: Xi's Europe trip carries forward friendship, charts the course for the future
05/13/20248:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZBRAZebra Technologies Corp
05/13/20248:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:GNKGenco Shipping and Trading Limited
05/13/20248:02PMGlobeNewswire Inc.GCC Announces Dividend Payment
05/13/20248:01PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:GNKGenco Shipping and Trading Limited
05/13/20248:00PMGlobeNewswire Inc.HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in ChinaNASDAQ:HCMHUTCHMED China Limited
05/13/20248:00PMGlobeNewswire Inc.HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with HengruiNASDAQ:HCMHUTCHMED China Limited
05/13/20248:00PMBusiness Wireスペイシャル、2024 1.0.1のリリースを発表

Your Recent History

Delayed Upgrade Clock